{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-052407","form_type":"8-K","ticker":"RIGL","cik":"0001034842","company_name":"RIGEL PHARMACEUTICALS INC","filed_at":"2025-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.229132+00:00","generated_at":"2026-05-20T12:55:55.636349+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Rigel stockholders approve 700,000-share increase to equity plan, re-elect directors","bullets":["Stockholders approved amendment to 2018 Equity Incentive Plan adding 700,000 shares.","Directors Kamil Ali-Jackson and Jane Wasman re-elected with 97.9% and 96.4% of votes cast, respectively.","Say-on-pay advisory resolution passed with 89.9% of votes cast.","Ratification of Ernst & Young as independent auditor approved with 93.1% of votes cast."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-052407","json":"https://secwatch.observer/filing/0001104659-25-052407.json","markdown":"https://secwatch.observer/filing/0001104659-25-052407.md","text":"https://secwatch.observer/filing/0001104659-25-052407.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1034842/000110465925052407/0001104659-25-052407-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1034842/000110465925052407/tm2516012d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T12:55:55.636349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}